Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Arch Gynecol Obstet ; 300(4): 1083-1092, 2019 10.
Article de Anglais | MEDLINE | ID: mdl-31529366

RÉSUMÉ

PURPOSE: To evaluate the impact of artificial oocyte activation (AOA) in pregnancy and neonatal outcomes in infertile patients undergoing cryopreserved embryo transfer. METHOD: This retrospective study included 5686 patients' transferred embryos from routine intracytoplasmic sperm injection (ICSI) and 194 patients' transferred embryos from ICSI combined with AOA (ICSI-AOA) from January 2011 to December 2016. Pregnancy and neonatal outcomes of couples undergoing routine ICSI or ICSI-AOA were analyzed before and after propensity score matching. Artificial oocyte activation was performed with ionomycin. RESULTS: The pregnancy outcomes showed no significant difference in the rates of biochemical pregnancy, clinical pregnancy, implantation, miscarriage, ectopic pregnancy, multiple pregnancy, and live births between the routine ICSI and ICSI-AOA groups before and after propensity score matching, respectively. The assessment of neonatal outcomes showed no statistically significant differences in the birth defect rate, birth weight, gestational age, preterm birth rate, early-neonatal death rate, and fetal sex ratio between the two groups, and similar results were also observed in the two matched cohorts. CONCLUSION: Artificial oocyte activation with ionomycin does not adversely affect pregnancy and neonatal outcomes in patients undergoing frozen-thawed embryo transfer, which is beneficial to clinicians counseling patients on the risks of artificial oocyte activation.


Sujet(s)
A-23187/effets indésirables , Ionophores calciques/effets indésirables , Transfert d'embryon/méthodes , Ovocytes/effets des médicaments et des substances chimiques , Avortement spontané , Adulte , Taux de natalité , A-23187/usage thérapeutique , Ionophores calciques/usage thérapeutique , Techniques de culture cellulaire , Cryoconservation , Implantation embryonnaire , Femelle , Humains , Infertilité , Naissance vivante , Mâle , Grossesse , Issue de la grossesse , Taux de grossesse , Grossesse multiple , Études rétrospectives , Appréciation des risques , Injections intracytoplasmiques de spermatozoïdes
2.
Mol Med Rep ; 17(1): 630-635, 2018 Jan.
Article de Anglais | MEDLINE | ID: mdl-29115448

RÉSUMÉ

Inflammation­associated damage may occur in any tissue following infection, exposure to toxins, following ischemia, and in allergic and auto­immune reactions. Inflammation may also result from mast cell degranulation induced by the intracellular calcium concentration. The inflammatory process may be inhibited by compounds that affect mast cells. Bisdemethoxycurcumin [1,7­bis(4­hydroxyphenyl) hepta­1,6­diene­3,5­dione, BDCM] is the active component of turmeric. It has anticancer, antioxidant and antibacterial properties. To investigate the molecular mechanism associated with the anti­inflammatory activity of BDCM, human mast cell line 1 (HMC­1) cells were treated with phorbol­12­myristate­13­acetate (PMA) and calcium ionophore A23187 (A23187) to induce the inflammatory process. Various HMC­1 cells were pretreated with BDCM prior to stimulation of inflammation. BDCM inhibited the inflammation­triggered production of cytokines including interleukin (IL)­6, IL­8, and tumor necrosis factor (TNF)­α. BDCM inhibition extended to the gene level. In activated HMC­1 cells, phosphorylation levels of extracellular signal­regulated kinase, c­jun N­terminal kinase and p38 mitogen­activated protein kinase were decreased by treatment with BDCM. BDCM also inhibited nuclear factor­(NF)­κB activation and IκB degradation. In conclusion, BDCM suppresses the expression of TNF­α, IL­8, and IL­6 by inhibiting the NF­κB and mitogen activated protein kinase signaling pathways.


Sujet(s)
Curcumine/analogues et dérivés , Inflammation/traitement médicamenteux , Facteur de transcription NF-kappa B/génétique , A-23187/effets indésirables , Lignée cellulaire , Curcumine/administration et posologie , Diarylheptanoïdes , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Humains , Inflammation/induit chimiquement , Inflammation/génétique , Inflammation/anatomopathologie , Mastocytes/métabolisme , Mastocytes/anatomopathologie , Mitogen-Activated Protein Kinase Kinases/génétique , Transduction du signal/effets des médicaments et des substances chimiques , 12-Myristate-13-acétate de phorbol/effets indésirables , 12-Myristate-13-acétate de phorbol/analogues et dérivés , Facteur de transcription RelA/génétique
3.
Reprod Biomed Online ; 31(4): 476-8, 2015 Oct.
Article de Anglais | MEDLINE | ID: mdl-26277587

RÉSUMÉ

In a recent report in Reproductive Biomedicine Online by Ebner et al., a comprehensive multi-centre study was presented on the use of a calcium ionophore, A23187, to artificially activate oocytes from patients who had poor fertilization rates in previous cycles. Under physiological conditions, the calcium increase in oocytes at activation is caused by influx and release from specific stores and ion channels, and has precise temporal, quantitative and spatial patterns. Calcium ionophores may release Ca(2+) in an uncontrolled fashion from intracellular stores that would not normally be involved in the activation process. Ionophores, including A23187, have a multitude of effects on cell homeostasis, not yet defined in oocytes, that may have long-term effects, for example on gene expression. We suspect that the successful births reported by Ebner et al. are a result of the overriding influence of the injected spermatozoa, rather than the effect of the ionophore; nevertheless, such an invasive non-physiological approach to assisted reproduction techniques is worrying, especially as epigenetic effects may result in future generations.


Sujet(s)
Techniques de reproduction assistée , A-23187/effets indésirables , A-23187/pharmacologie , Calcium/métabolisme , Ionophores calciques/effets indésirables , Ionophores calciques/pharmacologie , Femelle , Humains , Techniques de maturation in vitro des ovocytes/méthodes , Mâle , Ovocytes/effets des médicaments et des substances chimiques , Ovocytes/métabolisme , Grossesse , Techniques de reproduction assistée/effets indésirables , Injections intracytoplasmiques de spermatozoïdes
4.
Immunopharmacol Immunotoxicol ; 34(6): 991-1000, 2012 Dec.
Article de Anglais | MEDLINE | ID: mdl-22578178

RÉSUMÉ

CONTEXT: Chitin is the polysaccharide and is found in insects, parasites and fungi. Chitin has shown various immunological effects in in vivo and in vitro models. In this study, crystallinity controlled N-acetyl glucosamine (CCG) which has a high solubility was prepared from the low molecular weight chitosan. However, the effect of CCG in an allergic response is not clear. OBJECTIVE: To investigate the effect and regulatory mechanism of CCG on allergic responses. METHODS: To demonstrate the effect of CCG, we induced systemic anaphylactic shock, ear swelling response, passive cutaneous anaphylaxis (PCA), and inflammatory reaction. RESULTS: CCG inhibited the compound 48/80-induced systemic anaphylactic shock and ear swelling responses. IgE-mediated PCA was inhibited by the oral administration or topical application of CCG. Histamine and ß-hexosaminidase release from mast cells was decreased with the treatment of CCG. CCG also inhibited phorbol 12-myristate 13-acetate and calcium ionophore A23187-induced interleukin-1ß production and mRNA expression by suppressing NF-κB activation and IκBα phosphorylation. Furthermore, CCG suppressed the activation of caspase-1. CONCLUSION: These results suggest that CCG may have beneficial applicability as a candidate for an anti-allergic agent.


Sujet(s)
Acétyl-glucosamine/pharmacologie , Anaphylaxie/traitement médicamenteux , Antiallergiques/pharmacologie , Anaphylaxie/induit chimiquement , Anaphylaxie/immunologie , Anaphylaxie/métabolisme , Anaphylaxie/anatomopathologie , Animaux , A-23187/effets indésirables , A-23187/pharmacologie , Ionophores calciques/effets indésirables , Ionophores calciques/pharmacologie , Cancérogènes/pharmacologie , Caspase-1/immunologie , Caspase-1/métabolisme , Lignée cellulaire , Activation enzymatique/effets des médicaments et des substances chimiques , Activation enzymatique/immunologie , Régulation de l'expression des gènes/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes/immunologie , Hexosaminidases/immunologie , Hexosaminidases/métabolisme , Histamine/immunologie , Histamine/métabolisme , Humains , Interleukine-1 bêta/biosynthèse , Interleukine-1 bêta/immunologie , Mâle , Mastocytes/immunologie , Mastocytes/métabolisme , Souris , Souris de lignée ICR , ARN messager/biosynthèse , ARN messager/immunologie , Rats , Rat Sprague-Dawley , 12-Myristate-13-acétate de phorbol/effets indésirables , 12-Myristate-13-acétate de phorbol/pharmacologie
5.
Neurosci Lett ; 326(1): 51-5, 2002 Jun 21.
Article de Anglais | MEDLINE | ID: mdl-12052536

RÉSUMÉ

The E693G (Arctic) mutation of the amyloid precursor protein was recently found to lead to early-onset Alzheimer's disease in a Swedish family. In the present study, we report that the Arctic mutation decreases cell viability in human neuroblastoma cells. The cell viability, as measured by the MTT assay and propidium iodide staining, was further compromised following exposure to calcium ionophore A23187, microtubule-binding colchicine or oxidative stress inducer hydrogen peroxide. The manner of cell death was found to be apoptotic. During apoptosis, cells with the Arctic mutation also decreased their secretion of beta-secretase cleaved amyloid precursor protein. The enhanced sensitivity to toxic stress in cells with the Arctic mutation most likely contributes to the pathogenic pathway leading to Alzheimer's disease.


Sujet(s)
Maladie d'Alzheimer/génétique , Peptides bêta-amyloïdes/génétique , Apoptose/effets des médicaments et des substances chimiques , Mutation , Alcaloïdes/effets indésirables , Maladie d'Alzheimer/anatomopathologie , Précurseur de la protéine bêta-amyloïde/métabolisme , Technique de Western , A-23187/effets indésirables , Colchicine/effets indésirables , Humains , Peroxyde d'hydrogène/effets indésirables , Ionophores/effets indésirables , Neuroblastome , Cellules cancéreuses en culture
6.
Magn Reson Med ; 33(2): 200-8, 1995 Feb.
Article de Anglais | MEDLINE | ID: mdl-7707910

RÉSUMÉ

Dynamic MRI tracking of rat T-cells in vivo is performed in rat testicles after labeling isolated rat T-cells in vitro with superparamagnetic dextran-coated iron-oxide particles, BMS180549. Tissue inflammation induced by the local injection of the calcium ionophore, A23187, is used to attract labeled T-cells. Gradient-echo MR images of rat testicles show a statistically significant decrease (4%) of the signal intensity in areas of injection of A23187 as early as 30 min after intravenous infusion of 2 x 10(8) labeled T-cells. The signal change reaches its maximum (6-7% decrease) at about 60-120 min after cell infusion. T2-mapping also shows a decrease of T2 in the areas with A23187. Image quantitation, which includes a chemical-shift effect, significantly enhances the sensitivity for detection of superparamagnetically labeled T-cells. Localization of labeled T-cells in rat testicles has been verified by fluorescence microscopy studies of T-cells co-labeled with a lipophilic fluorescent carbocyanine dye, 1,1-dioctadecyl-3,3,3',3'-tetramethyl-lindocarbocyanine perchlorate. These results represent the first successful demonstration of dynamic tracking of specific cells in vivo using MRI.


Sujet(s)
Produits de contraste , Fer , Imagerie par résonance magnétique/méthodes , Oxydes , Lymphocytes T/physiologie , Testicule/anatomopathologie , Animaux , A-23187/effets indésirables , Carbocyanines , Mouvement cellulaire , Chimiotaxie , Oxyde ferrosoferrique , Technique d'immunofluorescence , Colorants fluorescents , Analyse de Fourier , Mâle , Microscopie de fluorescence , Orchite/induit chimiquement , Orchite/anatomopathologie , Rats , Rats de lignée F344 , Technique de soustraction , Lymphocytes T/anatomopathologie
7.
Invest Ophthalmol ; 15(10): 851-4, 1976 Oct.
Article de Anglais | MEDLINE | ID: mdl-789284

RÉSUMÉ

The ionophores A23187 and X537A, which increase the permeability of cell membranes to calcium and other divalent cations, produced significant elevation of intraocular pressure in rabbits. Topical instillation of these ionophores in concentrations of 1.0 and 0.1 per cent were effective. Aqueous humor protein and facility of outflow were similar in ionophore-treated and control eyes. Pretreatment with indomethacin did not block the intraocular pressure rise induced by A23187. Alterations of intracellular calcium might control cellular processes within the eye as in many other biological systems.


Sujet(s)
Pression intraoculaire/effets des médicaments et des substances chimiques , Ionophores/pharmacologie , Administration par voie topique , Animaux , Anti-inflammatoires/pharmacologie , Humeur aqueuse/effets des médicaments et des substances chimiques , A-23187/effets indésirables , A-23187/pharmacologie , Relation dose-effet des médicaments , Protéines de l'oeil/analyse , Glaucome/induit chimiquement , Indométacine/pharmacologie , Lasalocide/effets indésirables , Lasalocide/pharmacologie , Prednisolone , Prémédication , Lapins
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...